229
Views
29
CrossRef citations to date
0
Altmetric
Research Article

Th17 helper cell and T-cell immunoglobulin and mucin domain 3 involvement in Guillain–Barré syndrome

, , , , &
Pages 1039-1046 | Received 07 Feb 2012, Accepted 23 May 2012, Published online: 28 Jun 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Xiujuan Wu, Juan Wang, Kangding Liu, Jie Zhu & Hong-Liang Zhang. (2016) Are Th17 cells and their cytokines a therapeutic target in Guillain–Barré syndrome?. Expert Opinion on Therapeutic Targets 20:2, pages 209-222.
Read now
Hong-Liang Zhang, Limin Wu, Xiujuan Wu & Jie Zhu. (2014) Can IFN-γ be a therapeutic target in Guillain-Barré syndrome?. Expert Opinion on Therapeutic Targets 18:4, pages 355-363.
Read now

Articles from other publishers (27)

Aritrani Sarkar, Madhu Nagappa, Saikat Dey, Sandipan Mondal, Gopika Suresh Babu, Saptamita Pal Choudhury, Pokala Akhil & Monojit Debnath. (2023) Synergistic effects of immune checkpoints and checkpoint inhibitors in inflammatory neuropathies: Implications and mechanisms. Journal of the Peripheral Nervous System.
Crossref
Abhishek Shastri, Ahmad Al Aiyan, Uday Kishore & Maria Elena Farrugia. (2023) Immune-Mediated Neuropathies: Pathophysiology and Management. International Journal of Molecular Sciences 24:8, pages 7288.
Crossref
Amin Safa, Tahereh Azimi, Arezou Sayad, Mohammad Taheri & Soudeh Ghafouri-Fard. (2020) A review of the role of genetic factors in Guillain–Barré syndrome. Journal of Molecular Neuroscience 71:5, pages 902-920.
Crossref
Kathleen M. Hagen & Shalina S. Ousman. (2021) The Neuroimmunology of Guillain-Barré Syndrome and the Potential Role of an Aging Immune System. Frontiers in Aging Neuroscience 12.
Crossref
Hayriye Soytürk & Murat Yılmaz. (2020) A comparison of IL-17 and IL-34 concentrations in the cerebrospinal fluid of patients with acute inflammatory demyelinating neuropathy and chronic inflammatory demyelinating polyneuropathy. Revista da Associação Médica Brasileira 66:11, pages 1583-1588.
Crossref
Lizhen Zhao, Guoyi Yu, Qi Han, Congxian Cui & Bei Zhang. (2020) TIM‐3: An emerging target in the liver diseases. Scandinavian Journal of Immunology 91:4.
Crossref
Ting Sun, Xi Chen, Sha Shi, Qingshan Liu & Yong Cheng. (2019) Peripheral Blood and Cerebrospinal Fluid Cytokine Levels in Guillain Barré Syndrome: A Systematic Review and Meta-Analysis. Frontiers in Neuroscience 13.
Crossref
Zahra Ebrahim Soltani, Farzaneh Rahmani & Nima Rezaei. (2019) Autoimmunity and cytokines in Guillain-Barré syndrome revisited: review of pathomechanisms with an eye on therapeutic options. European Cytokine Network 30:1, pages 1-14.
Crossref
Monojit Debnath, Madhu Nagappa, Manjula Subbanna, Pandarisamy Sundaravadivel, Pinku Mani Talukdar, Venkataram Shivakumar, Rahul Wahatule, Debprasad Dutta, B. Binukumar, Sanjib Sinha, Parayil Sankaran Bindu, Sundar Periyavan, G.S. Umamaheswara Rao & Arun B. Taly. (2018) Th17 pathway signatures in a large Indian cohort of Guillain Barré syndrome. Journal of Neuroimmunology 323, pages 125-130.
Crossref
Xiuju Chen, Ying Guo, Ranran Han, Haijie Liu, Yanan Ding, Yanchao Shi, Dexin Kong & Xiaofeng Ma. (2018) Class I PI3K inhibitor ZSTK474 attenuates experimental autoimmune neuritis by decreasing the frequency of Th1/Th17 cells and reducing the production of proinflammatory cytokines. Cellular Immunology 329, pages 41-49.
Crossref
Gerwyn Morris, Tatiana Barichello, Brendon Stubbs, Cristiano A. Köhler, André F. Carvalho & Michael Maes. (2017) Zika Virus as an Emerging Neuropathogen: Mechanisms of Neurovirulence and Neuro-Immune Interactions. Molecular Neurobiology 55:5, pages 4160-4184.
Crossref
Monojit Debnath, Madhu Nagappa, Geetanjali Murari & Arun B. Taly. (2018) IL-23/IL-17 immune axis in Guillain Barré Syndrome: Exploring newer vistas for understanding pathobiology and therapeutic implications. Cytokine 103, pages 77-82.
Crossref
Haijie Liu, Chunxiao Wan, Yanan Ding, Ranran Han, Yating He, Jinting Xiao & Junwei Hao. (2017) PR‐957, a selective inhibitor of immunoproteasome subunit low‐MW polypeptide 7, attenuates experimental autoimmune neuritis by suppressing T h 17‐cell differentiation and regulating cytokine production . The FASEB Journal 31:4, pages 1756-1766.
Crossref
Yanan Ding, Ranran Han, Wei Jiang, Jinting Xiao, Haijie Liu, Xiuju Chen, Xiaowen Li & Junwei Hao. (2016) Programmed Death Ligand 1 Plays a Neuroprotective Role in Experimental Autoimmune Neuritis by Controlling Peripheral Nervous System Inflammation of Rats. The Journal of Immunology 197:10, pages 3831-3840.
Crossref
Yuan Liu, Li-Fen Gao, Xiao-Hong Liang & Chun-Hong Ma. (2016) Role of Tim-3 in hepatitis B virus infection: An overview. World Journal of Gastroenterology 22:7, pages 2294-2303.
Crossref
Abhishek Saxena. (2016) Probiotics as a Potential Alternative for Relieving Peripheral Neuropathies: a Case for Guillain-Barré Syndrome. Frontiers in Microbiology 6.
Crossref
Ning Xin, Michael Peter Namaka, Changxin Dou & Yong Zhang. (2015) Exploring the role of interleukin-22 in neurological and autoimmune disorders. International Immunopharmacology 28:2, pages 1076-1083.
Crossref
Nurcan Üçeyler, Nadja Riediger, Waldemar Kafke & Claudia Sommer. (2014) Differential gene expression of cytokines and neurotrophic factors in nerve and skin of patients with peripheral neuropathies. Journal of Neurology 262:1, pages 203-212.
Crossref
Simon Rinaldi & David L.H. Bennett. (2014) Pathogenic mechanisms in inflammatory and paraproteinaemic peripheral neuropathies. Current Opinion in Neurology 27:5, pages 541-551.
Crossref
X. Wang, X.-Y. Zheng, C. Ma, X.-K. Wang, J. Wu, A. Adem, J. Zhu & H.-L. Zhang. (2014) Mitigated Tregs and Augmented Th17 Cells and Cytokines are Associated with Severity of Experimental Autoimmune Neuritis. Scandinavian Journal of Immunology 80:3, pages 180-190.
Crossref
Hua Xu, Xiao-Li Li, Long-Tao Yue, Heng Li, Min Zhang, Shan Wang, Cong-Cong Wang & Rui-Sheng Duan. (2014) Therapeutic potential of atorvastatin-modified dendritic cells in experimental autoimmune neuritis by decreased Th1/Th17 cytokines and up-regulated T regulatory cells and NKR-P1+ cells. Journal of Neuroimmunology 269:1-2, pages 28-37.
Crossref
Mark Stettner, Birthe Lohmann, Kathleen Wolffram, Jan-Philipp Weinberger, Thomas Dehmel, Hans-Peter Hartung, Anne K Mausberg & Bernd C Kieseier. (2014) Interleukin-17 impedes Schwann cell-mediated myelination. Journal of Neuroinflammation 11:1, pages 63.
Crossref
Kishan Kumar Nyati & Kashi Nath Prasad. (2014) Role of Cytokines and Toll-Like Receptors in the Immunopathogenesis of Guillain-Barré Syndrome. Mediators of Inflammation 2014, pages 1-10.
Crossref
Rong kun Han, Yue feng Cheng, Shan shan Zhou, Hong Guo, Rui dong He, Li jun Chi & Li ming Zhang. (2013) Increased Circulating Th17 Cell Populations and Elevated CSF Osteopontin and IL-17 Concentrations in Patients with Guillain-Barré Syndrome. Journal of Clinical Immunology 34:1, pages 94-103.
Crossref
Xu Wang, Chi Ma, Jiang Wu & Jie Zhu. (2013) Roles of T helper 17 cells and interleukin‐17 in neuroautoimmune diseases with emphasis on multiple sclerosis and Guillain‐Barré syndrome as well as their animal models. Journal of Neuroscience Research 91:7, pages 871-881.
Crossref
Kishan Kumar Nyati & Roopanshi Nyati. (2013) Role of Campylobacter jejuni Infection in the Pathogenesis of Guillain-Barré Syndrome: An Update . BioMed Research International 2013, pages 1-13.
Crossref
Owen Ngalamika, Yiqun Zhang, Heng Yin, Ming Zhao, M. Eric Gershwin & Qianjin Lu. (2012) Epigenetics, autoimmunity and hematologic malignancies: A comprehensive review. Journal of Autoimmunity 39:4, pages 451-465.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.